Sponsor:
Memorial Sloan Kettering Cancer Center
Code:
NCT05239533
Conditions
Clear Cell Renal Cell Carcinoma
Kidney Cancer
Advanced Renal Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
177Lu-labeled-girentuximab
Nivolumab
89Zr-girentuximab PET/CT
177Lu whole body (WB) planar and SPECT/CT scans
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-17. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-05-18.